tiprankstipranks
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market

Prime Medicine, Inc. (PRME) Financial Statements

Compare
594 Followers

Prime Medicine, Inc. Financial Overview

Prime Medicine, Inc.'s market cap is currently $410.53M. The company's EPS TTM is $-2.014; its P/E ratio is ―; Prime Medicine, Inc. is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 5.21M$ 0.00
Gross Profit$ -147.91M$ 0.00$ 0.00$ 0.00$ -2.76M
Operating Income$ -191.29M$ -116.54M$ -84.47M$ -932.00K$ -2.17M
EBITDA$ -193.76M$ -110.75M$ -160.99M$ -889.00K$ -2.17M
Net Income$ -198.13M$ -121.82M$ -165.37M$ -3.41M$ -2.53M
Balance Sheet
Cash & Short-Term Investments$ 121.67M$ 293.92M$ 269.62M$ 53.33M$ 8.65M
Total Assets$ 193.85M$ 360.31M$ 301.86M$ 54.78M$ 8.70M
Total Debt$ 13.63M$ 28.75M$ 10.41M$ 17.52K$ 0.00
Net Debt$ -27.94M$ -158.88M$ -175.01M$ -36.96M$ -8.65M
Total Liabilities$ 60.78M$ 360.31M$ 62.30M$ 21.31M$ 7.31M
Stockholders' Equity$ 133.07M$ -293.58M$ 239.56M$ 33.47M$ 1.39M
Cash Flow
Free Cash Flow$ -174.14M$ -147.92M$ -38.23M$ -6.18M$ -1.33M
Operating Cash Flow$ -165.41M$ -131.83M$ -34.08M$ -5.54M$ -1.33M
Investing Cash Flow$ 18.71M$ -47.10M$ -73.63M$ -1.06M$ 0.00
Financing Cash Flow$ 655.00K$ 181.49M$ 269.28M$ 34.93M$ 9.98M
Currency in USD

Prime Medicine, Inc. Earnings and Revenue History

Prime Medicine, Inc. Debt to Assets

Prime Medicine, Inc. Cash Flow

Prime Medicine, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis